Filing Flows › Comparisons › ELAB vs KRRO
Pmgc Holdings vs Korro Bio: ELAB and KRRO compared
Pmgc Holdings is the larger company: $1.3M of revenue in its latest quarter (Q2 2026) against $1.3M for Korro Bio (Q4 2025).
Where the money goes: ELAB and KRRO
Pmgc Holdings (ELAB) · Q2 2026
Pmgc Holdings, Q2 2026: revenue $1.3M, operating margin -225.1%, net loss $2.9M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
Korro Bio (KRRO) · Q4 2025
Korro Bio, Q4 2025: revenue $1.3M (-43% year over year), net loss $50.0M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
| Pmgc Holdings (ELAB) | Korro Bio (KRRO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2025 |
| Revenue | $1.3M | $1.3M |
| Revenue growth, Y/Y | — | -43% |
| Operating margin | -225.1% | n/m |
| Net earnings | −$2.9M | −$50.0M |
| Net margin | -225.1% | — |
| Operating cash flow | −$2.0M | −$17.7M |
Questions
Which is bigger, Pmgc Holdings or Korro Bio?
Pmgc Holdings is the larger company: $1.3M of revenue in its latest quarter (Q2 2026) against $1.3M for Korro Bio (Q4 2025).
More: Pmgc Holdings earnings · how Pmgc Holdings makes money · Korro Bio earnings · how Korro Bio makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-K filed Mar 12, 2026). Fiscal quarters can end on different dates. Not investment advice.